SKAN Group Ltd header image

SKAN Group Ltd

SKAN

Equity

ISIN CH0013396012 / Valor 1339601

SIX Swiss Exchange (2026-10-02)
CHF 67.80-1.45%

SKAN Group Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

SKAN Group Ltd is a company specializing in the development and support of isolators and related equipment, primarily serving industries that require stringent contamination control, such as pharmaceuticals and biotechnology. The company offers a range of services under its SKANalytix brand, focusing on data analysis, evaluation, and documentation to enhance the performance and compliance of isolators. These services include assessing the cleanability of isolators, developing tailored cleaning processes, and evaluating the impact of hydrogen peroxide on sterility tests. SKAN adheres to Good Manufacturing Practice (GMP) standards, ensuring high-quality service execution and documentation. To address the challenges posed by evolving user specifications, production changes, and regulatory updates, SKAN provides options for upgrading existing equipment, integrating the latest technologies to extend the lifespan and functionality of isolators. Additionally, SKAN offers a comprehensive LifeCycle Support portfolio, including a 24-hour emergency service hotline staffed by specialists to ensure minimal downtime and optimal operation of isolators.

Summarized from source with an LLMView SourceSector: Industrials

Latest Results (25.09.2026):

SKAN Group Ltd — Annual results for full-year 2025 (not a quarterly report): SKAN reported FY 2025 order intake of CHF 370.6 million (+3.1% vs 2024) and an order backlog of CHF 346.1 million (+8.7%). Net sales fell to CHF 333.3 million (-7.7% reported; -6.4% currency-adjusted). EBITDA declined to CHF 38.6 million (-32.3%) with an EBITDA margin of 11.6% (vs 15.8% in 2024). Profit for the period was CHF 17.6 million (-56.9%) and EPS was CHF 0.72 (vs CHF 1.73). The Board proposes a dividend of CHF 0.22 per share and gives a confident outlook for 2026 (net sales growth expected in the high‑teens; EBITDA margin guidance 13–15%).

Top-line and backlog

Order intake: CHF 370.6m (+3.1%). Order backlog: CHF 346.1m (+8.7%), providing solid revenue visibility despite project phasing and some potential cancellation exposure (~CHF 15–20m).

Revenue and regional mix

Net sales: CHF 333.3m (-7.7% reported). Europe remained the largest market; Americas and Asia showed mixed performance (Americas down vs prior year, Asia up on conversion of prior awards). Services & Consumables grew to ~35% of Group sales.

Profitability

EBITDA: CHF 38.6m (-32.3%), margin 11.6% (2024: 15.8%). Profit for the period: CHF 17.6m (-56.9%). EPS: CHF 0.72 (-58.1%). Decline driven by lower project-related sales in Equipment & Solutions and higher other operating expenses, partly offset by stronger Services & Consumables performance.

Segment performance

Equipment & Solutions: order intake CHF 248.5m (-2.6%), net sales CHF 216.8m (-20.0%), EBITDA CHF 9.4m (4.3%). Services & Consumables: order intake CHF 122.2m (+17.0%), net sales CHF 116.5m (+28.9%), EBITDA CHF 29.2m (25.0%).

Cash flow, investments and balance sheet

Operating cash flow increased to CHF 64.1m (+37.3%). Investments (PPE & intangibles) CHF ~45.9m (-14.7%), with significant spending on Pre‑Approved Services and R&D (~7.4% of net sales). Equity at year‑end CHF 127.6m (equity ratio 26.5%, down from 52.7%), reflecting goodwill offsets related to acquisitions.

M&A, headcount and strategic initiatives

Acquisitions: Metronik and ABC Transfer consolidated from August 2025 (adding ~208 employees). Headcount rose to 1,755 (+19.3%). SKAN is pushing Services & Consumables, digital solutions (MES) and Pre‑Approved Services; continued R&D and product development including pure2 isolator and ebeam milestones.

Outlook and corporate changes

Management expects 2026 net sales growth in the high‑teens and an EBITDA margin of 13–15%. Board proposes CHF 0.22 dividend per share and will propose a new Board member. CEO change effective 1 Jan 2026 (Jonas Greutert designated CEO).

Summarized from source with an LLMView Source

Key figures

20.9%1Y
-8.99%3Y
%5Y

Performance

36.9%1Y
30.3%3Y
34.4%5Y

Volatility

Market cap

1839 M

Market cap (USD)

Daily traded volume (Shares)

21,887

Daily traded volume (Shares)

1 day high/low

78.2 / 76.2

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Air Liquide SA
Air Liquide SA Air Liquide SA Valor: 502455
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.24%EUR 170.16
Vinci SA
Vinci SA Vinci SA Valor: 508670
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%EUR 106.80
SAFRAN SA
SAFRAN SA SAFRAN SA Valor: 829036
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.95%EUR 330.10
Thales SA
Thales SA Thales SA Valor: 524726
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.15%EUR 222.70
Balchem Corp
Balchem Corp Balchem Corp Valor: 910930
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.75%USD 166.56
Axcelis Technologies Inc
Axcelis Technologies Inc Axcelis Technologies Inc Valor: 33120856
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.09%USD 147.77
Knorr-Bremse AG
Knorr-Bremse AG Knorr-Bremse AG Valor: 43005909
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.17%EUR 99.20
Innospec Inc
Innospec Inc Innospec Inc Valor: 2429839
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.35%USD 97.41
Vicat SA
Vicat SA Vicat SA Valor: 510004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.38%EUR 58.80
Lisi SA
Lisi SA Lisi SA Valor: 494737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%EUR 60.30